Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.0 - $23.99 $0 - $107 Million
-4,441,260 Closed
0 $0
Q3 2023

Feb 14, 2024

BUY
$21.54 - $24.41 $95.7 Million - $108 Million
4,441,260 New
4,441,260 $101 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Davidson Kempner Capital Management LP Portfolio

Follow Davidson Kempner Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Kempner Capital Management LP with notifications on news.